Acceptability of the Wand for young dental patients
Research type
Research Study
Full title
Assessing acceptability of the Wand anaesthetic system for paediatric dental patients a pilot trial
IRAS ID
184896
Contact name
Paul Ashley
Contact email
Sponsor organisation
University College London
Clinicaltrials.gov Identifier
Z6364106/2019/10/132, Data protection registration number
Duration of Study in the UK
0 years, 1 months, 30 days
Research summary
This study is planned to compare the children's acceptability of local anaesthetic (LA) when delivered by the Wand computer-controlled local anaesthetic delivery system CCLAD in one group to LA delivered by the conventional dental injection in the other group.
Dental injections are used to inject the local anaesthetic LA to a specific site of the oral cavity as an essential measure to provide a painless dental treatment. However, injection pain is one of the most common evoking stimuli of dental anxiety (Taani et al., 2005). One of the recent advancement in reducing discomfort associated with the delivery of LA is the computer-controlled local anaesthetic device CCLAD named the ‘Wand®. The past two decades witnessed a considerable rise in the employment of this tool in reducing discomfort caused by injecting the anaesthetic into the oral tissue particularly with children. This pilot trial will assess the acceptability of both tools and find out whether an impact on the children's level of anxiety exists.
In this pilot trial, children 10 -16 yrs. who require non urgent dental treatment under local anaesthetic will be invited to express their opinion about how acceptable the LA they had.
The trial is single-sited and will run at Eastman Dental Hospital for an estimated period of 60 days. Participants will be assented, and their parents/legal guardians will be consented on the day of the trial. Every participant will then complete an anxiety scale and a prospective acceptability rating profile before receiving the treatment. After receiving the LA immediately, each participant will complete an acceptability visual analogue scale then, after completion of the treatment, each participant will complete another anxiety scale, a retrospective acceptability rating profile and a needle fear scale. By achieving this stage, the trial should be completed for each participant. The duration will be the normal treatment time added to the time every participant require to complete the scales in addition to obtaining the consent/assent which is estimated to be approx. 60-90 mins.REC name
East of Scotland Research Ethics Service REC 2
REC reference
20/ES/0017
Date of REC Opinion
13 Feb 2020
REC opinion
Unfavourable Opinion